These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35114585)

  • 1. ISRIB plus bortezomib triggers paraptosis in breast cancer cells via enhanced translation and subsequent proteotoxic stress.
    Lee DM; Seo MJ; Lee HJ; Jin HJ; Choi KS
    Biochem Biophys Res Commun; 2022 Mar; 596():56-62. PubMed ID: 35114585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lercanidipine Synergistically Enhances Bortezomib Cytotoxicity in Cancer Cells via Enhanced Endoplasmic Reticulum Stress and Mitochondrial Ca
    Lee AR; Seo MJ; Kim J; Lee DM; Kim IY; Yoon MJ; Hoon H; Choi KS
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis.
    Lee DM; Kim IY; Seo MJ; Kwon MR; Choi KS
    Exp Mol Med; 2017 Aug; 49(8):e365. PubMed ID: 28798402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells.
    Seo MJ; Kim IY; Lee DM; Park YJ; Cho MY; Jin HJ; Choi KS
    Cell Death Dis; 2023 Jan; 14(1):42. PubMed ID: 36658130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress.
    Kawaguchi T; Miyazawa K; Moriya S; Ohtomo T; Che XF; Naito M; Itoh M; Tomoda A
    Int J Oncol; 2011 Mar; 38(3):643-54. PubMed ID: 21174067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death.
    Kim IY; Shim MJ; Lee DM; Lee AR; Kim MA; Yoon MJ; Kwon MR; Lee HI; Seo MJ; Choi YW; Choi KS
    Biochem Pharmacol; 2019 Apr; 162():41-54. PubMed ID: 30529689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors.
    Prelowska MK; Mehlich D; Ugurlu MT; Kedzierska H; Cwiek A; Kosnik A; Kaminska K; Marusiak AA; Nowis D
    Cancer Lett; 2021 Jun; 507():13-25. PubMed ID: 33713737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress.
    Wallington-Beddoe CT; Bennett MK; Vandyke K; Davies L; Zebol JR; Moretti PAB; Pitman MR; Hewett DR; Zannettino ACW; Pitson SM
    Oncotarget; 2017 Jul; 8(27):43602-43616. PubMed ID: 28467788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca
    Lee HJ; Lee DM; Seo MJ; Kang HC; Kwon SK; Choi KS
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine tuning of the unfolded protein response by ISRIB improves neuronal survival in a model of amyotrophic lateral sclerosis.
    Bugallo R; Marlin E; Baltanás A; Toledo E; Ferrero R; Vinueza-Gavilanes R; Larrea L; Arrasate M; Aragón T
    Cell Death Dis; 2020 May; 11(5):397. PubMed ID: 32457286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells.
    Kawabata S; Gills JJ; Mercado-Matos JR; Lopiccolo J; Wilson W; Hollander MC; Dennis PA
    Cell Death Dis; 2012 Jul; 3(7):e353. PubMed ID: 22825471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines.
    Miyahara K; Kazama H; Kokuba H; Komatsu S; Hirota A; Takemura J; Hirasawa K; Moriya S; Abe A; Hiramoto M; Ishikawa T; Miyazawa K
    Int J Oncol; 2016 Nov; 49(5):1848-1858. PubMed ID: 27601063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response.
    Sidrauski C; Tsai JC; Kampmann M; Hearn BR; Vedantham P; Jaishankar P; Sokabe M; Mendez AS; Newton BW; Tang EL; Verschueren E; Johnson JR; Krogan NJ; Fraser CS; Weissman JS; Renslo AR; Walter P
    Elife; 2015 Apr; 4():e07314. PubMed ID: 25875391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule ISRIB suppresses the integrated stress response within a defined window of activation.
    Rabouw HH; Langereis MA; Anand AA; Visser LJ; de Groot RJ; Walter P; van Kuppeveld FJM
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2097-2102. PubMed ID: 30674674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells.
    Meister S; Frey B; Lang VR; Gaipl US; Schett G; Schlötzer-Schrehardt U; Voll RE
    Neoplasia; 2010 Jul; 12(7):550-61. PubMed ID: 20651984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B.
    Zyryanova AF; Weis F; Faille A; Alard AA; Crespillo-Casado A; Sekine Y; Harding HP; Allen F; Parts L; Fromont C; Fischer PM; Warren AJ; Ron D
    Science; 2018 Mar; 359(6383):1533-1536. PubMed ID: 29599245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress responses. Mutations in a translation initiation factor identify the target of a memory-enhancing compound.
    Sekine Y; Zyryanova A; Crespillo-Casado A; Fischer PM; Harding HP; Ron D
    Science; 2015 May; 348(6238):1027-30. PubMed ID: 25858979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The small molecule ISRIB reverses the effects of eIF2α phosphorylation on translation and stress granule assembly.
    Sidrauski C; McGeachy AM; Ingolia NT; Walter P
    Elife; 2015 Feb; 4():. PubMed ID: 25719440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic enhancement of ER stress by insulin-like growth factor I sensitizes myeloma cells to proteasomal inhibitors.
    Tagoug I; Jordheim LP; Herveau S; Matera EL; Huber AL; Chettab K; Manié S; Dumontet C
    Clin Cancer Res; 2013 Jul; 19(13):3556-66. PubMed ID: 23674497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors.
    Hu H; Petrosyan A; Osna NA; Liu T; Olou AA; Alakhova DY; Singh PK; Kabanov AV; Faber EA; Bronich TK
    J Control Release; 2019 Jul; 306():149-164. PubMed ID: 31121280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.